1 / 14

Hospital Competition and Reimbursement

Hospital Competition and Reimbursement. Econ 737.01 3/1/11. Outline. I. Competition under a cost-based reimbursement system II. Competition under a prospective payment system III. Competition under managed care. I. Competition under a cost-based reimbursement system.

bazyli
Download Presentation

Hospital Competition and Reimbursement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hospital Competition and Reimbursement Econ 737.01 3/1/11

  2. Outline • I. Competition under a cost-based reimbursement system • II. Competition under a prospective payment system • III. Competition under managed care

  3. I. Competition under a cost-based reimbursement system • Hospital reimbursement was cost-based through the early 1980s => little incentive to keep costs down • Physicians and patients made the decisions about which hospital to choose, yet insurance paid most of the bill => price competition ineffective • How would you therefore expect hospitals to compete with each other?

  4. I. Competition under a cost-based reimbursement system • During this period, hospitals tended to compete by continually trying to “one-up” each other in terms of quality • Ways to do this included investing in the latest technology (regardless of its cost-effectiveness), hiring more staff, and improving amenities • This phenomenon is known as the “medical arms race” (MAR)

  5. I. Competition under a cost-based reimbursement system • Example: Two hospitals are deciding whether to purchase the latest MRI machine, which costs $2.5 M. If neither or both purchase it, they keep their existing market shares. If only one purchases it, it will steal $5 M of business from the one that does not.

  6. I. Competition under a cost-based reimbursement system • Nash equilibrium: both hospitals will purchase the machine and each lose $2.5 M • Cooperative outcome: neither purchase it • The hospitals are therefore trapped in a prisoner’s dilemma that will lead to excessive investment. • This simple example ignores other factors such as patient utility and potentially higher reimbursement rates. • However, it is sufficient to illustrate the idea that competition could actually increase hospital costs

  7. I. Competition under a cost-based reimbursement system • Empirical evidence on the MAR • Robinson and Luft (1985): More competing hospitals within 15 miles => higher costs per admission • Robinson et al. (1988, 1987, and 1986): More competing hospitals => higher employee/patient ratio and more of a variety of specialty services • Zwanziger and Melnick (1988): Competition increased hospital costs in CA in 1983 but not 1985; they attributed this to increased managed care • Conner et al. (1997): Found evidence of non-price competition in 1986 that shifted to price competition by 1994 • Dranove et al. (1992): More thorough set of control variables; competition only increased supply of 2 of 13 specialty services in CA in 1983

  8. II. Competition under a prospective payment system • Medicare Prospective Payment System (PPS) (1983) • Switched from cost-based to diagnostic related group-based reimbursement. • Theoretical effect on incentives • Incentive to undertreat? • Shleifer(1985): incentive to select most efficient production tecnhology • Dranove (1987): incentive to dump sickest patients within a DRG onto local public hospital • Allen and Gertler (1991): model showing that hospitals would undertreat relatively ill patients and overtreat relatively healthy patients within a DRG; mixed reimbursement scheme based partially on DRG and partially on cost is needed • Other papers support finding that mixed scheme needed to optimally balance cost and quality

  9. II. Competition under a prospective payment system • Empirical evidence • Ellis and McGuire (1996): New Hampshire Medicaid switching from cost-based reimbursement to PPS in 1989 reduced length of inpatient stays for psychiatric patients • Newhouse (1989): hospitals more likely to admit patients in profitable Medicare DRGs, but do not transfer unprofitable patients to other hospitals after admission • Cutler (1995): Changes in reimbursement levels after implementation of Medicare DRG system negatively correlated with inpatient mortality

  10. II. Competition under a prospective payment system • Utilization review (UR) • When a health insurance company reviews a request for treatment (either proactively or retroactively) to determine if it is appropriate • Along with the PPS, Medicare implemented UR through Peer Review Organizations (PROs). • Many private insurers also began implementing UR in the 1980s, almost all did by late 1990s.

  11. II. Competition under a prospective payment system • UR • Positives • Addresses moral hazard problem created by third party payers (like a supervisor) • Addresses asymmetric information issue between doctors and patients • Helps spread information from medical outcomes research to physicians • Empirical evidence suggests it does reduce inpatient utilization • Negatives • Extra layer of bureaucracy • Are the services being eliminated actually the wasteful ones?

  12. II. Competition under a prospective payment system • Cost-shifting • When hospitals respond to reduction in prices from one payer (i.e. Medicare or Medicaid) by raising prices for another payer (i.e. private insurance) • Would not make sense for a for-profit hospital but might in a non-profit (Dranove, 1988) • In order to cost-shift, hospitals would need to have the power to change prices for privately-insured patients (which is hard with managed care) • The most credible empirical evidence suggests that hospitals used to cost-shift but don’t anymore, probably because of the rise of managed care

  13. III. Competition under managed care • Managed care is essentially the result of private insurers trying to exercise control over prices and utilization the same way public insurers did • Payers created organizations that contracted with providers to obtain discounted prices • Patients given strong financial incentives to use these “in-network” providers • Payer essentially acts as the “shopper” on behalf of the patient • Providers are willing to offer these discounted prices because of the large volume of patients the managed care organization brings

  14. III. Competition under managed care • Theoretically, we would expect managed care to increase the price elasticity of demand and therefore bring competition back to the price dimension instead of just the quality dimension • Empirical test: what is the effect of market concentration on price? • Lower concentration (more competition) increasing price: consistent with quality competition (MAR) • Lower concentration (more competition) decreasing price: consistent with price competition • The most credible empirical evidence (Dranove et al., 1993) suggests that lower concentration switched from increasing price in the early 1980s to decreasing price in the late 1980s, consistent with a switch from quality to price competition caused by the penetration of managed care • This has obvious antitrust implications.

More Related